State Street Corp Ligand Pharmaceuticals Inc Transaction History

State Street Corp

$2.59 Trillion
Q2 2025

A detailed history of State Street Corp transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, State Street Corp holds 749,754 shares of LGND stock, worth $114 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

749,754

Previous 727,125 3.11%

Holding current value

$114 Million

Previous $76.4 Million 11.49%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$96.67 - $118.22 $2.19 Million - $2.68 Million	22,629 Added 3.11%	749,754 $85.2 Million
Q1 2025 May 15, 2025	SELL	$105.14 - $122.23 $1.74 Million - $2.02 Million	-16,507 Reduced 2.22%	727,125 $76.4 Million
Q4 2024 Feb 14, 2025	BUY	$99.95 - $129.9 $3.62 Million - $4.7 Million	36,218 Added 5.12%	743,632 $79.7 Million
Q3 2024 Nov 14, 2024	BUY	$82.7 - $110.11 $1.54 Million - $2.05 Million	18,642 Added 2.71%	707,414 $70.9 Million
Q2 2024 Aug 14, 2024	BUY	$68.53 - $87.91 $1.2 Million - $1.54 Million	17,488 Added 2.61%	688,772 $58 Million
Q1 2024 May 15, 2024	BUY	$68.64 - $89.2 $205,920 - $267,600	3,000 Added 0.45%	671,284 $49.1 Million
Q4 2023 Feb 14, 2024	BUY	$49.57 - $72.63 $2.23 Million - $3.27 Million	45,029 Added 7.22%	668,284 $47.7 Million
Q3 2023 Nov 14, 2023	BUY	$58.86 - $72.67 $626,446 - $773,426	10,643 Added 1.74%	623,255 $37.3 Million
Q2 2023 Aug 14, 2023	SELL	$69.53 - $79.33 $2.29 Million - $2.61 Million	-32,946 Reduced 5.1%	612,612 $44.2 Million
Q1 2023 May 15, 2023	SELL	$65.67 - $77.08 $286,058 - $335,760	-4,356 Reduced 0.67%	645,558 $47.5 Million
Q4 2022 Feb 14, 2023	SELL	$61.72 - $96.74 $18.6 Million - $29.2 Million	-301,404 Reduced 31.68%	649,914 $43.4 Million
Q3 2022 Nov 15, 2022	SELL	$0.01 - $107.56 $1,325 - $14.3 Million	-132,599 Reduced 12.23%	951,318 $81.9 Million
Q2 2022 Aug 15, 2022	SELL	$74.52 - $117.06 $586,919 - $921,964	-7,876 Reduced 0.72%	1,083,917 $96.7 Million
Q1 2022 May 16, 2022	BUY	$94.99 - $151.56 $19.4 Million - $31 Million	204,440 Added 23.04%	1,091,793 $123 Million
Q4 2021 Feb 14, 2022	SELL	$127.69 - $165.85 $3.94 Million - $5.12 Million	-30,860 Reduced 3.36%	887,353 $137 Million
Q3 2021 Nov 15, 2021	BUY	$102.33 - $144.73 $6.01 Million - $8.51 Million	58,765 Added 6.84%	918,213 $128 Million
Q2 2021 Aug 16, 2021	BUY	$113.03 - $155.64 $8.67 Million - $11.9 Million	76,688 Added 9.8%	859,448 $113 Million
Q1 2021 May 17, 2021	SELL	$99.52 - $215.83 $38.1 Million - $82.6 Million	-382,630 Reduced 32.83%	782,760 $119 Million
Q4 2020 Feb 16, 2021	BUY	$80.55 - $106.05 $15.6 Million - $20.5 Million	193,763 Added 19.94%	1,165,390 $116 Million
Q3 2020 Nov 10, 2020	SELL	$89.56 - $126.72 $3.45 Million - $4.89 Million	-38,561 Reduced 3.82%	971,627 $92.6 Million
Q2 2020 Aug 14, 2020	SELL	$68.28 - $123.65 $16.6 Million - $30 Million	-242,570 Reduced 19.36%	1,010,188 $113 Million
Q1 2020 May 11, 2020	BUY	$63.37 - $107.88 $79.4 Million - $135 Million	1,252,758 New	1,252,758 $91.1 Million

Others Institutions Holding LGND

# of Institutions

289

Shares Held

19.5M

Call Options Held

Put Options Held

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.58B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Ligand Pharmaceuticals Inc Transaction History